◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Sumitomo Pharma Co.,Ltd. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
+Revenue 136.4B 98.2B 231.8B 302.4B 313.9B
Revenue Growth % 38.9% -57.6% -23.4% -3.7% --
+Operating Income 28.8B -354.9B -77.0B 60.2B 71.2B
Operating Margin % 21.1% -361.3% -33.2% 19.9% 22.7%
Non Operating Income 10.4B 48.2B 53.8B 33.3B 13.9B
Non Operating Expenses 10.0B 4.7B 4.0B 3.6B 5.7B
Ordinary Income 12.0B -6.5B 104.8B 140.9B 135.9B
Income Before Taxes 17.6B -323.1B -47.9B 83.0B 77.9B
Income Taxes -6.0B -8.2B 48.8B 42.4B 41.0B
+Net Income 23.6B -315.0B -74.5B 56.4B 56.2B
Net Margin % 17.3% -320.7% -32.2% 18.7% 17.9%
Eps 267.28 -1,480 -460.52 147.81 293.23
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
Cash And Deposits 23.1B 29.0B 143.5B 203.0B 193.7B
Current Assets 253.2B 269.6B 381.9B 499.5B 459.8B
Property Plant Equipment 46.6B 57.9B 58.9B 64.1B 65.0B
Noncurrent Assets 489.4B 637.9B 752.9B 808.5B 848.3B
Total Assets 523.4B 645.4B 1089.0B 1187.9B 1172.6B
Current Liabilities 85.8B 365.3B 151.6B 77.6B 82.9B
Total Liabilities 573.1B 751.4B 728.0B 634.4B 659.9B
Retained Earnings 46.8B -22.7B 281.0B 514.2B 508.7B
Total Equity 158.9B 108.4B 675.3B 850.4B 810.2B
Equity Ratio 0.30 0.17 0.62 0.72 0.69
Book Value Per Share 399.98 272.79 1,700 2,140 2,039
Num Employees 3,832 4,980 6,250 6,987 6,822
Roe 0.80 -- -- 0.07 0.15
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
Operating Cash Flow 16.5B -241.9B 11.9B 31.2B 135.6B
Investing Cash Flow 99.8B 33.0B 52.4B -18.3B 8.9B
Financing Cash Flow -108.8B 77.9B -146.8B -21.4B -57.2B
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...